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Abstract 
Duchenne muscular dystrophy (DMD) is an X-linked recessive muscle wasting disease caused by mutations in the DMD gene, which 
encodes the large cytoskeletal protein dystrophin. Approximately one-third of DMD patient’s exhibit cognitive problems yet it is unknown 
if cognitive impairments worsen with age. The mdx mouse model is deficient in dystrophin demonstrates cognitive abnormalities, but no 
studies have investigated this longitudinally. We assessed the consequences of dystrophin deficiency on brain morphology and cognition in 
male mdx mice. We utilised non-invasive methods to monitor CNS pathology with an aim to identify changes longitudinally (between 4 and 
18 months old) which could be used as outcome measures. MRI identified a total brain volume (TBV) increase in control mice with ageing 
( p < 0.05); but the mdx mice TBV increased significantly more ( p < 0.01). Voxel-based morphometry (VBM) identified decreases in grey 
matter volume, particularly in the hippocampus of the mdx brain, most noticeable from 12 months onwards, as were enlarged lateral ventricles 
in mdx mice. The caudate putamen of older mdx mice showed increases in T 2 - relaxometry which may be considered as evidence of increased 
water content. Hippocampal spatial learning and memory was decreased in mdx mice, particularly long-term memory, which progressively 
worsened with age. The novel object recognition (NOR) task highlighted elevated anxiety-related behaviour in older mdx mice. Our studies 
suggest that dystrophin deficiency causes a progressive cognitive impairment in mice (compared to ageing control mice), becoming evident 
at late disease stages, and may explain why progressive CNS symptoms are not obvious in DMD patients. 
© 2020 The Authors. Published by Elsevier B.V. 
This is an open access article under the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 
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Duchenne muscular dystrophy (DMD) is an X-linked
recessive disease, occurring at an incidence of 1 in 3600–
10,000 live male births [1 , 2] . DMD is characterised by
a severe pathology of the skeletal musculature causing
progressive loss of muscle, with premature death frequently
occurring in the third decade of life as a result of cardiac and
respiratory complications [3] . This fatal disease arises from
mutations in the DMD gene; the largest gene in the human
genome, with 79 exons spanning 2.4 Mb [4] , and coding for a
427 kDa intracellular protein named dystrophin [5] . Although∗ Corresponding author. 
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( http://creativecommons.org/licenses/by/4.0/ ) ystrophin is most abundantly expressed in muscle tissues,
t is also expressed in the central nervous system (CNS)
ith the brain harbouring high amounts of various dystrophin
soforms [6 , 7] . Considerable research has been devoted to
nderstanding the role of dystrophin in muscle cells; its role
n the brain has received less attention until more recently. 
Intellectual impairment has long been recognised as a
isease symptom in DMD [8] , and developmental delay has
lso been detailed by clinicians to be amongst the first signs
t disease presentation. It is now generally acknowledged that
he average IQ of DMD patients is 85, one standard deviation
elow the norm [9 , 10] and there is a higher incidence of
eurodevelopmental disorders observed [11] . DMD patients
isplay a varying degree of memory impairments, which
ave been attributed to the loss of dystrophin in brainss article under the CC BY license. 
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o  tructures involved in cognition, including the cerebellum
nd hippocampus, with approximately one-third of patients
isplaying some degree of cognitive deficit frequently
anifesting itself in memory impairment, but ranging from
educed verbal intelligence [10 , 12] to severe autism [13 , 14] .
ithin the CNS full-length-dystrophin is highly expressed in
yramidal neurons of the hippocampus, which has important
oles in memory formation and consolidation [6] . 
The DMD gene has 7 promoters resulting in various sized
ystrophin protein products. The promoters located in the
roximal region of the gene gives rise to three full-length
ystrophin isoforms: Dp427b (brain) found predominantly in
ortical neurons, Dp427m (muscle) and Dp427p (Purkinje)
ound to be expressed in mouse Purkinje cells but recently
dentified to be absent from the human cerebellum [15] . In
dditional to full-length dystrophin, there are five smaller
ystrophin isoforms expressed in various body tissues.
p140, Dp71, and Dp40 are also expressed in brain tissue,
ith cognitive impairment most prominent in patients with
utations in distal region of the DMD gene, which eliminates
he expression of full-length dystrophin and one or more
horter dystrophin isoforms. 
Many investigators have postulated roles for the
ystrophin-glycoprotein complex (DGC) in the CNS, but
nambiguous evidence has yet to emerge. Current literature
uggests that neuronal DGC composition is complex, with
umerous isoforms expressed in different tissues and neuron
pecific localisation [16 , 17] . It has been suggested that
he DGC may be acting as an adaptor between the actin
ytoskeleton and membrane bound receptors acting to anchor
olecules which are critical for neuronal functioning [18] .
he DGC may also participate in the formation and
aintenance of macromolecular signalling complexes [19] .
urthermore, it is hypothesised that dystrophin may play a
ole in stabilising the postsynaptic apparatus during brain
aturation in order to maintain a certain network status
ritical for synaptic plasticity [20] . Dp427, for example,
as been found to colocalise with GABA A receptors,
nd it is hypothesised that following GABA A receptor
nsertion into the neural membrane, dystrophin is essential
or their anchoring and clustering, which in turn is
ecessary for correct signal transduction. As a consequence,
ateral diffusion of these receptors may be inhibited, hence
ontributing to their stabilisation [17 , 21] . Other dystrophin
soforms appear to be expressed in a cell-specific manner:
p140 appears to be associated with microvascular glia cells
22] , Dp116 is most abundantly found in Schwann cells of
eripheral nerves, and Dp71 is the most highly expressed
ystrophin in the brain (under control of the general promotor
G-dystrophin)) and is expressed in both neurons and glia
23] . 
There is conclusive evidence that the muscle pathology
xhibited by DMD is progressive, and although previous
tudies have defined the cognitive deficit observed in DMD
atients to be non-progressive [24] , recent investigations are
eginning to investigate cognitive impairment in older DMD
atients (mean age 30.4 years old) compared to healthyontrols [25] . Additionally, these previous studies do not
orrelate intellectual abilities with functional brain changes in
he dystrophin deficient brain. Interestingly, recent research
as identified progressive cognitive impairments in a small
ohort of DMD patients. A significant decline in GABA A 
eceptors within the prefrontal cortices in DMD patients was
dentified with this observed decline more pronounced in
lder adult DMD patients (30–37 years old) [26] . Moreover,
lder DMD patients had an age-related decline in Wisconsin
ard Sorting Test (WCST), a test predominately used to
ssess executive functions (strategic planning, organized 
earching, behavioural direction toward achieving a goal),
ompared to younger DMD adult patients (18–25 years
ld) which suggests that cognitive dysfunction does in
act progresses with age [26] . These studies demonstrate a
rogressive cognitive decline in older DMD patients, but
hese patients are still relatively young (within their 30 ′ s) and
uggests that cognition would deteriorate with increased age
ompared to healthy controls. 
The most important mouse model for pre-clinical research
n DMD is the mdx mouse. This model is routinely used
or drug development, with the main focus upon treatment
f muscle pathology. Previous studies in the mdx mouse
ave also shown deficits in passive avoidance learning [27] ,
mpairments in memory consolidation (both spatial and
on-spatial learning) [28] , and retention deficits at long
elays in spontaneous alteration and bar pressing tasks [29] .
ne major caveat of the cognitive assessment testing in the
dx mouse is the lack of monitoring of potential progressive
ognitive defects. 
As therapy development for DMD has rapidly expanded
n recent years, there is urgent need to develop reliable
utcome measures to monitor disease progression and efficacy
f treatment interventions. Successful clinical trials are reliant
pon the validity of outcome measures, which are developed
n the preclinical phase, to monitor the effect of a given
ntervention. Inaccurate preclinical work generating poor 
utcome measures hinders the utility of future clinical trials,
s any observed effect may not truly be attributable to the
ntervention in question. It is important that standardised
eproducible outcome measures are available to monitor
ognitive dysfunction in the mdx mouse similar to those
lready available for assessing muscle pathology [30] . The
imited number of sensitive outcome measures to assess and
onitor the DMD brain phenotype, together with the need
o avoid invasive techniques in patients makes magnetic
esonance imaging (MRI) a particularly attractive option. 
To date, almost all studies investigating cognitive
ysfunction in DMD patients and in the mdx mice have
etailed outcomes from cross-sectional studies using only a
ingle age group. However, given that recent reports indicate
hat cognitive disability increases in DMD patients with
ncreasing age [26] , there is a need to assess how this disease
arameter is effected by age. Consequently, the overall aim of
his study was to apply already established techniques to non-
nvasively monitor cognition and brain function in mdx mice
ver time. Following a longitudinal assessment of a cohort
370 E. Bagdatlioglu, P. Porcari and E. Greally et al. / Neuromuscular Disorders 30 (2020) 368–388 
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a  of male mdx mice we found progressive changes in the brain
morphology and cognitive abilities. 
2. Materials and methods 
The investigations conformed to the Guide for the Care
and Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No.85-23, revised in
1985) and was performed under the terms of the Animals
Scientific Procedures Act 1986, authorised by the Home
Secretary, Home Office UK. All experiments were performed
at the animal care facility of Newcastle University, UK. The
study was approved by the Ethical Review Committee of
Newcastle University. All animal experiments were performed
under project licence number: PB3CA650C. 
3. Animals 
Male mdx ( C57BL/10 ScSn-mdx/J ) mice were purchased from
Jackson laboratories (Bar harbour, ME, USA) and male
control ( C57BL/10 ScSnOlaHsd ) mice were purchased from
Harlan Laboratories (Indianapolis, USA). Mdx mice were bred
with a homozygote male and a hemizygote female. This study
utilised separate well established colonies of WT and mdx
mice and did not use mdx mice littermate controls. Both
genotypes are bred onto a C57BL/10 background and are
long-term colonies in our animal facility. Mice were group
housed (4 mice per cage) under controlled temperature (17–
28 °C) and light conditions (12:12 h light:dark cycle). Animals
had free access to food and water. 
3.1. Magnetic resonance imaging (MRI) 
3.1.1. Data acquisition 
MR images were acquired using a 7.0 Tesla horizontal bore
Varian scanner (Varian Medical System, Palo Alto, CA, USA)
equipped with a 12-cm inner diameter actively shielded 37
gradient set (Magnex Scientific, Oxford, UK). A 39 mm (inner
diameter) volume coil (Rapid Biomedical GmbH, Germany)
was used as a radiofrequency (RF) transceiver for MR
imaging of mouse brain. 
Images were obtained following induction of anaesthesia
with 4% Isoflurane (Abbott, USA) and 0.5 l/min oxygen in
an anaesthetic chamber. For MRI brain examination, mice
were laid prone on a home-made mouse holder keeping
the head fixed by a bite bar in order to ensure that the
head was positioned at the isocenter of the magnet. Body
temperature was maintained using a warm air device (SA
Instruments) set at 37 °C with monitoring via a rectal probe.
Anaesthesia was maintained using 1.5% Isoflurane and 0.5
l/min oxygen via a nose cone controlled with regard to
respiratory effort ( ∼50 bpm), monitored through an MRI-
compatible small animal monitoring and gating system. 
The MRI protocol included scout images to determine
the correct positioning of the mouse brain, T 2 -
weighted ( T 2 -w) fast spin-echo (FSE) images and
T 1 -weighted ( T 1 -w) spin-echo (SE) images. For eachouse, axial, sagittal, and coronal T 2 -w images were
cquired using the following parameters: repetition
ime/effective echo time (TR/TE eff ) = 7000/40 ms, number
f averages = 4, field of view (FOV) = 25 ×25 mm 2 , matrix
MTX) = 256 ×256, in plane resolution = 98 μm ×98 μm,
lice thickness = 0.7 mm. Coronal T 1 -w SE images
ere acquired for each mouse using the following
arameters: TR/TE = 900/16.07 ms, number of averages = 4,
OV = 25 ×25 mm 2 , MTX = 256 ×256, in plane
esolution = 98 μm ×98 μm and slice thickness = 0.7 mm.
he acquisition time for T 1 w and T 2 w imaging was 15 min
er sequence. 
T 2 relaxation times of different brain regions
hippocampus, caudate putamen, cerebral cortex, corpus
allosum, cerebellum) of control and mdx mice aged 6 and
8 months old were determined using a multi-echo-multi-
lice (MEMS) sequence (TR/TE = 3500/8 ms, NE = 12, 18
lices, slice thickness = 1 mm, interslice gap = 0 mm in plane
esolution = 196 ×196 μm 2 ). For all FSE and SE protocols
ontiguous slices were obtained in an interleaved manner.
 2 -maps of mouse brain were computed for each slice on a
oxel by voxel basis fitting the signal decay to the standard
ingle exponential decay (with time constant T 2 ) as a function
f TE (12 echo times were employed, starting from 8 to
6 ms with an echo spacing of 8 ms). The acquisition time
or the T 2 mapping protocol was 15 min. 
The animals spent on average a total of 90 min inside the
RI scanner per session. 
.1.2. Brain volume estimations 
Tissue volumes for whole brain and regional structures
hippocampus, cerebellum, ventricles) were estimated from
he average values obtained from the T 2 -w scans utilising
ll orthogonal views. On average, 5 slices were used to
alculate regional structural volumes. The cross sectional
reas of each structure were determined by drawing regions
f interest (ROIs) on each slice of the MRI images
sing ImageJ software ( http:// rsb.info.nih.gov/ ij/ ). ROIs were
utlined according to The Allen Mouse Brain Atlas ( http:
/ mouse.brain-map.org/ ). Total volume of each structure was
hen calculated for each mouse according to the following
ormula: 
otal Brain Volume = n j=1 d · A j (1)
here A j is the cross sectional area on the j th slice
hrough the mouse brain, n indicates the total number of the
onsidered slices and d the slice thickness (0.7 mm). 
All orthogonal views (sagittal, coronal, axial) and both
 1 - w and T 2 - w images were utilised for brain volume
stimations. 
.1.3. Voxel-based morphometry (VBM) 
VBM describes the automated process of analysing
orphological differences between images of the brain by
erforming voxel-wise statistics comparing groups of animals.
BM registers all mice into the same stereotaxic space
ccounting for differences in overall brain size and shape and
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t  hen detects morphological changes regardless of changes in
verall total brain volume (TBV). 
T 2 -w MR images were processed using SPM12 software
Wellcome Department of Clinical Neurology, London; http:
/www.fil.ion.ucl.ac.uk). VBM was performed utilising the
ethods detailed by Sawiak et al. [31] and the freely available
PMMouse software package ( http:// www.spmmouse.org/ )
as used to provide the grey matter (GM) tissue probability
ap. 
Following pre-processing, structural measures were 
odelled in a general linear model (GLM) to test hypotheses.
n appropriate model for our study was a two-sample
tudent’s t -test between the mdx and the control C57BL/10
ouse brains. The images of this longitudinal brain study
ere acquired in- vivo with a relatively short scan time per
ouse (15 min for a T 2 -weighted image) and as such the
mage quality was lower than the ex-vivo SPMMouse brain
emplate used for the segmentations steps. With such a
arge number of tests, correction for multiple comparisons
as necessary and we used the false-discovery rate (FDR)
echnique [32] with a threshold of p ≤0.05 for statistical
ignificance. 
The mdx mice developed kyphosis by the age of 18
onths [33] and consequently this influenced how the mice
ay in the MRI scanner. Due to this we had to perform a
anual reorientation on all the mdx mouse brains in SPM12
rior to beginning with the SPMMouse segmentation (see
upplementary Material 1 for more detail). 
For all MRI experiments 8 mice per genotype we
epeatedly scanned between 4 and 18 months old in order
o longitudinally assess anatomical brain changes in the same
nimal. 
.1.4. Radiography 
Mice were briefly anaesthetised with 5% Isoflurane in an
naesthetic chamber. Radiographs (X-rays) were performed 
n 18 month old mice with a Faxitron radiography system
Faxitron X-Ray, Lincolnshire, IL) at 23 kV for 5 s. DICOM
aw images were then imported into ImageJ ( https://imagej.
ih.gov/ ij/ ), and skull length measurements calculated by
etermining the width of the parietal plate and length of the
asal plate. 
.1.5. Barnes maze testing 
For all behavioural experiments mice were briefly handled
y their tail in order to be placed into a small black tray used
or transportation to the test arena. This approach was chosen
o minimise handling and reduced stress. 
We followed the same procedure as described by Sunyer
t al. [34] . In brief, mice were given 3 min to explore the
aze and locate the target hole (TH) associated with the
arget shape. In this time the primary errors (nose pokes
ot in the TH before it is found), total errors (number of
rrors committed before entering TH throughout the whole
rial), primary latency (time to find the TH), and total latency
time to enter the TH) were recorded. Once inside the targetox, located beneath the TH, the mice were left for 1 min
efore being returned to their home cages. There were 4
rials per day for 4 consecutive days, and in between each
rial the mice were given a 15-min interval inside their home
age. 
On day 5 (probe trial 1), the target box was removed.
he TH for each mouse was the same as on previous days.
he mice were allowed to explore the maze for 90 s and
n that time a number of measures were recorded: primary
atency, primary errors, total errors, and the preference for
oles around the maze (total head pokes in individual holes
round the maze). From the head pokes in various holes
round the maze we created a success score. This was the
umber of head pokes in a hole, multiplied by a given value
or that hole. Values were based on orientation around the
arget hole; with the target hole itself having a value of
0. The score for the individual holes was then totalled to
reate an overall success score. On day 12 (probe trial 2), the
ame procedure as on day 5 was performed with no training
ccurring between days 5 and 12. 
We did not use any aversive stimuli. If mice failed to enter
he TH during the allocated 3 min they were given a 1-min
enalty in order to differentiate between the mice that entered
n exactly 3 min and those that did not. 
The behavioural tests commenced at the same time each
ay. As manual measurements were taken during the testing
e.g., number of errors) the investigator became a spatial cue
nd as such remained in the same position throughout the
ntire testing (i.e., across the training days and probe trials).
he same investigator performed all behavioural testing and
RI scanning. 
.1.6. The novel object recognition (NOR) task 
Mice were given a 10-min habituation to an arena of
imensions 48 ×31 ×20 cm once a day for 4 consecutive
ays. On the fifth day, mice were exposed to the NOR task
n two phases. In the first phase (sample), mice explored two
dentical objects (A1 and A2) for 3 min. Objects were either
olystyrene spheres or stars, depending on randomisation.
bjects were chosen based on difference in shape, to ensure
ovelty in the trials and also similarity in size to the mice.
ice were then given a 15-min inter-trial retention delay.
ice were then exposed to the second (choice) phase, in
hich the identical objects were replaced by one novel object
B1) and one familiar object (A3), and again mice explored
hese for 3 min. 
Average time spent with the objects was recorded in both
hases of testing. From this, D2 ratios’ were calculated for
tatistical analysis of the choice (test) phase. These create
 value between + 1 and −1, where + 1 is total preference
or the novel object, −1 is total preference for the familiar
bject, and 0 is no preference for either object. D2 ratios were
alculated by determining the proportion of total time spent
xploring either of the objects (B1-A3/B1 + A3) [35 , 36] . 
For all behavioural assessments 8 mice per genotype
etween 4 and 12 months were examined. We excluded
he 18 month old time point from behavioural investigations
372 E. Bagdatlioglu, P. Porcari and E. Greally et al. / Neuromuscular Disorders 30 (2020) 368–388 
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r  as it is argued that by this age mdx mice begin
to demonstrate extensive muscle pathology which could
impact mobility during both the Barnes maze and NOR
tasks [37–39] . 
3.1.7. Measurement of stereotypical behavioural 
Stereotypical behaviour observed during behavioural
testing was defined as a motor response which was repetitive,
invariant, and seemingly without purpose or goal. Repetitive
jumping, rearing, or circling the walls of the arena during the
task were considered as a stereotypical behaviour unrelated
to the behavioural tasks during this current study. 
3.2. Statistics 
All statistics were performed using IBM SPSS Statistics
22.0 software. A repeated measures ANOVA was used for
multiple measurements taken from the same mouse over time
(MRI longitudinal study, total/primary latency from Barnes
maze testing) with students paired t -test used as post-hoc
testing where a significant main effect was identified. A two-
way ANOVA was used for T 2 relaxation rates (6 and 18
months old), D2 ratio from the NOR task (4, 6, and 12
months old), and Barnes maze probe trials (at 4, 6, and
12 months). Bonferoni ad-hoc tests were used to determine
where differences lay. A student’s two-tailed t -test was used
to compare control to mdx mice brain at 6 months and 12
months following VBM analysis. Level of significance was
set at p < 0.05, or very significant p < 0.01. All graphs are
presented as mean ± SEM. 
3.3. Data availability 
The data from this study is available upon request from
the corresponding author (volker.straub@newcastle.ac.uk). 
4. Results 
4.1. Longitudinal non-invasive imaging 
The objective of this study was to investigate structural and
functional changes in the CNS of mdx mice over time. We
first determined the total brain volume (TBV) of mdx mice
using non-invasive imaging ( Fig. 1 a). 
4.2. Enlarged TBV in mdx mice 
Between 4 months and 18 months old control mouse brains
increased by a total of 5.29 ±1.03% with the largest increase
in TBV observed between 6 months and 12 months old
(3.05 ±1.03%). The mdx mouse brain also increased in size
between 4 months and 18 months old with an even larger
TBV increase of 7.52 ±1.38%, in contrast to the surge in
increase of TBV observed in control mice, the mdx mice
brains steadily increased in size between 4 months and 18
months old ( Fig. 1 b–d). Taken together, the results indicate
that the control mouse TBV increases in size by a smallut significant amount between 4 months and 18 months
ld ( p < 0.05). However, the mdx mouse TBV increased
onsiderably more ( p < 0.01). There was a significant
ain effect between genotype ∗age on TBV ( F 3,53 = 26.22,
 < 0.01). 
.3. Changes in lateral ventricle volume in the mdx mice 
The mdx mice brain ventricles were enlarged compared
o age matched control mice ( Fig. 2 a,b). The dilation of
ateral ventricles was particularly prominent in the coronal
nd axial MR images acquired and increased lateral ventricle
olume was also observed ( Fig. 2 c), although this finding
luded statistical significance until 12 months old between
ontrol and mdx mice ( p < 0.01, control vs. mdx mice)
 Fig. 3 a–d). The ventricles were larger in mice aged 4
onths old compared to mice aged 6 months old for both
he control and mdx mice, suggesting that the brain volume
ncreases faster than the brain ventricular system, given that
hese measurements are relative ( Fig. 3 a,b). There was a
ignificant main effect between genotype ∗age on ventricle
olume ( F 3,29 = 6.62, p = 0.01). Additionally, the mdx mice
ost weight from 12 months onwards, whereas the control
ice gained a significant amount of weight between 12
nd 18 months old ( Fig. 1 c). There was a significant main
ffect between genotype ∗age on body weight ( F 3,62 = 32.72,
 < 0.01). 
.4. No difference in cerebellar volume between control and 
dx mice 
The cerebellum is a grey and white matter structure at the
osterior end of the brain which has a distinctive web-like
ppearance seen in all three orthogonal views, the distinctive
ppearance is the result of the white matter cerebellar lobule
trips appearing hypointense in a T 2 -weighted image. In
he axial view, the cerebellum is located superior to the
 V, the pons and the medulla ( Fig. 1 a). Fig. 4 b shows
he paraflocculus and flocculus lobules, with which the
rus 1 ansiform lobule and the simple lobule make up the
ateral cerebellar regions and have thus been included in all
erebellar volume measurements. There was no interaction
etween age ∗genotype on cerebellar volume ( F 7,43 = 2.84,
 = 0.339). 
The volume of the cerebellum was measured from serial
oronal T 2 - weighted MR images of control and mdx mice,
overing the same anatomical region in the brain and collected
etween 4 and 18 months old. We found no differences in the
erebellar volume (when expressed as a percentage of TBV)
etween control and mdx mice at any time point investigated
 Fig. 4 a–e). 
.5. No difference in hippocampal volume between control 
nd mdx mice 
The volume of the hippocampus was measured using
epresentative T 2 - weighted MR images from control and
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Fig. 1. a–c: Longitudinal total brain volume (TBV) measurements. a . Representative images demonstrating the method used for estimation of total brain 
volume (TBV) in all mice using the polygon tool in ImageJ. The outline of each brain structure from representative T 1 -w coronal and T 2 -w -coronal, -axial 
and -sagittal images are delineated in green. b. Bar graph displaying longitudinal comparison of TBV. MRI derived TBV for mice at 4 months old, 6 months 
old, 12 months old and 18 months old ( n = 8 mice per genotype at each time point). The control mouse brain increased in volume between 4 and 18 months 
old ( p < 0.05). The mdx mice had a larger TBV compared to control mice from 12 months onwards ( p < 0.01). Between 12 and 18 months old the mdx 
mice had a significantly larger TBV compared to control mice ( p < 0.05). c . Line graph showing average body weights of mice used for the longitudinal 
MR imaging study. At 4 months old all mice have a comparable body weight. Between 12 and 18 months mdx mice begin to lose weight whereas control 
mice gain weight. Data presented as mean ± SEM, ∗p < 0.05, ∗∗p < 0.01 for control vs. mdx, ^ p < 0.05, ^^ p < 0.01 for changes observed with ageing in 
mdx mice, $ < p .0.05 for changes observed with ageing in control mice. d. Line graph displaying the rate of change in TBV between 4 and 18 months old in 
control C57BL/10 and mdx mice. 
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p  dx mice covering the same anatomical region in the brain
nd collected between 4 and 18 months old. The whole
ippocampus (CA1, CA3, DG and general hippocampal areas)
as utilised for hippocampal volume estimations ( Fig. 5 a).
erial T 2 - weighted MR images were considered in order to
ccurately measure the entire volume of the hippocampus.
verall, we did not find any statistically significant difference
n the volume of the hippocampus (when expressed as a
ercentage of TBV) between control and mdx mice at any
ime point investigated ( Fig. 5 a–d). There was no interaction
etween age ∗genotype on hippocampal volume ( p = 0.14). .6. Changes in T 2 relaxation rates detected in the mdx 
ouse brain at 18 months old 
Quantitative MRI acquisition and analysis techniques allow
nvestigations beyond conventional qualitative interpretation 
nd provide further insights into brain pathologies.
elaxometry combines acquisition and analysis techniques to
enerate MR relaxation time constants that directly reflect the
ocal environment of water. Since the transverse relaxation
ime, T 2 , is a quantitative measure of a basic biophysical
roperty, which leads to signal contrast on MRI, it can
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Fig. 2. a–c: Longitudinal ventricular volume measurements a. Representative T 2 -w coronal MR images displaying increased lateral ventricles in mdx mice at 
12 months old. Sagittal images where the red line indicates approximately where the coronal slice was acquired through the mouse brain. b. Representative 
T 2 -w axial MR images displaying increased lateral ventricle volume in mdx mice at 18 months old. Sagittal images where the red line indicates approximately 
where the axial slice was acquired through the mouse brain. c. Bar graph displaying the relative total ventricle volume between 4 and 18 months old. Relative 
total ventricle volume is calculated based on the total volume of the ventricle system expressed as a percentage of total brain volume. At 4 and 6 months old 
there was no difference between control and mdx total ventricle volume ( p > 0.05). However, between 12 and 18 months old the mdx mice had a significantly 
higher total ventricle volume compared to age matched control mice ( p < 0.05). Additionally, the relative total ventricle volume increased between 4 and 18 
months old in both genotypes, but this increased volume was substantially larger in mdx mice ( p < 0.01) compared to control mice ( p < 0.05). Data presented 
as mean ± SEM, ∗p < 0.05, ∗∗p < 0.01 for control vs. mdx , ^ p < 0.05, ^^ p < 0.01 for changes observed with ageing in mdx mice, $ < p .0.05 for changes 
observed with ageing in control mice. 
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ROI. provide a quantitative monitoring tool in both healthy and
disease states. Increases in brain water T 2 are associated
with oedema (water content) and with changes to tissue
microstructure. 
We recorded the T 2 relaxation times at 7T for numerous
ROIs, including the cerebral cortex, corpus callosum,
hippocampus, cerebellum, and caudate putamen, in mdx
and control mouse brains at 6 and 18 months old (see
Supplementary Material 2 for more detail). At 6 months
old, no observation of change in T 2 relaxation time wasound in any ROI of either the control or mdx mouse
rains ( Fig. 6 a) suggesting that the brain microstructure
nd water content between control and mdx mouse brain is
omparable at this time point ( p = 0.61). Interestingly, at 18
onths old there was an elevated T 2 relaxation rate within
he caudate putamen of the mdx mouse brain (significant
nteraction between age ∗genotype for the caudate putamen
 F 0.016,0.09 = 4.61. p = 0.05) ( Fig. 6 b), therefore suggestive of
ascular changes such as increased water content within this
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Fig. 3. a–d: Bar graphs displaying relative ventricle volume between 4 and 18 months old. LV = lateral ventricles, 3V = third ventricle, D3V = dorsal third 
ventricle and 4V = fourth ventricle. a. Relative ventricle volume at 4 months old showing no difference in ventricle volume between control and mdx mice. 
b. Relative ventricle volume at 6 months old showing increased volume of the LVs in mdx mice but was not found to be significant ( P = 0.06). c. Relative 
ventricle volume at 12 months old showing increased LV volume in mdx mice compared to aged matched control mice ( p < 0.01). d. Relative ventricle volume 
at 18 months old showing increased LV volume in mdx mice compared to aged matched control mice ( p < 0.01). Data presented as mean ± SEM, ∗p < 0.05, 
∗∗ p < 0.01, n = 8 mice per genotype at each time point. 
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a  .7. Progressive changes in grey matter (GM) volume in the 
dx brain 
VBM was applied to the mdx mouse brain between 6 and
8 months old. At 6 months old there was little difference in
M of control and mdx mice with changes observed mainly
round the lateral ventricles and hippocampus, as well as the
ermal cerebellum ( Fig. 7 a,b). 
At 18 months old, VBM detected the largest number
f differences between the control and mdx mouse brains.
he GM was larger in control mice brains in numerous
rain regions (following students paired t -test) including the
halamus, the inferior colliculus, the somatosensory cortex,
nd the hippocampus. In contrast, the mdx mouse brain
ad a larger GM volume than the control mice in various
egions, mainly the cerebral cortex (lower layers), basal lateral
mygdala nucleus, and the cingulate cortex ( Fig. 7 a,b). .8. Temporalis muscle hypertrophy in mdx mice 
It has previously been demonstrated that the average
emporal muscle thickness was significantly increased in
MD patients when compared to aged matched controls. In
ddition a rounder shape of the head compared to more ovoid
haped in healthy controls was also observed [40] . We found
hat the overall head shape of mdx mice differed to that of
ontrol mice, as indicated by temporal muscle hypertrophy
bserved qualitatively in Fig. 8 a. We made measurements
rom both the right and left temporal muscle ( Fig. 8 b)
nd found bilateral temporal muscle widening in mdx mice
etween 6 and 12 months old ( Fig. 8 c,d), in addition to
ranial changes ( Fig. 8 e). There appears to be changes in the
ead circumference, with mdx mice showing a larger, slightly
ounder head shape at older ages ( Fig. 8 a–e). Radiographs
lso showed that mdx mice had a shortening of the nasal plate
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Fig. 4. a–e: Longitudinal cerebellar volume measurements . a. Representative coronal T 2 - w MR image of control mouse cerebellum delineated in red following 
ROI analysis in ImageJ. b. T 2 -w coronal MR image showing the paraflocculus and floculus lobules of the lateral cerebellum (red arrows) included in total 
cerebellar volume measurements. c . Sagittal T 2 -w MR image where red line indicates approximately where the coronal slice was acquired through the mouse 
brain. d. Representative T 2 - w images displaying the cerebellum from the same control and mdx mice between 6 and 18 months old. No gross anatomical 
differences were observed. e. Bar graph displaying relative cerebellar volume at all-time points investigated. We detected no changes in the relative cerebellar 
volume between control and mdx mice between 6 and 18 months old ( p > 0.05). Relative cerebellar volume is calculated based on the total volume of the 
cerebellum expressed as a percentage of total brain volume. Data presented as mean ± SEM, n = 8 mice per genotype at each time point. 
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Fig. 5. a–d: Longitudinal hippocampal volume measurement. a. Representative coronal T 2 - w MR image of control mouse hippocampus (red insert) following 
ROI analysis in ImageJ . b. Sagittal T 2 - w MR image where red line indicates approximately where the coronal slice was acquired through the mouse brain. c. 
Representative T 2 - w images displaying the hippocampus from the same control and mdx mice between 6 and 18 months old. No gross anatomical differences 
were observed. d. Bar graph displaying relative hippocampal volume at all-time points investigated. Relative hippocampal volume is calculated based on the 
total volume of the hippocampus expressed as a percentage of total brain volume. We detected no changes in the relative hippocampal volume between control 
and mdx mice between 6 and 18 months old ( p > 0.05). Data presented as mean ± SEM following students t -test for control vs. mdx mice, n = 8 mice per 
genotype at each time point. 
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Fig. 6. a,b: Comparison of T 2 relaxation times of each selected brain region between control and mdx mice. a. At 6 months old there was no difference in 
the relaxation rate in any ROI between the control and mdx mice. b. At 18 months there was an elevated T 2 relaxation rate in the caudate putamen of mdx 
mice compared to aged matched control mice ( p < 0.05). Data are presented as mean ± SEM, ∗p < 0.05, n = 4 mice per genotype at each time point. 
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m  and widening of the parietal plate at 12 months old ( Fig. 8 e,f)
contributing to a change in skull morphology. Additionally
these findings are in congruence with previous studies, where
no difference in skull morphology was identified in 3 month
old mice [41] , as it is only with increased age that we
identified cranial changes. 
4.9. Longitudinal cognitive profiling 
To assess if cognitive impairment is progressive in mdx
mice we performed two behavioural assays: the Barnes
maze test and the novel object recognition (NOR) test,
both of which rely upon intact hippocampal function
[42] (see Supplementary material 3 for behavioural testing
overview). .10. Barnes maze testing identified progressive deficits in 
he long-term memory of mdx mice 
The Barnes maze test was performed on separate cohorts
f control and mdx mice aged 4–12 months old. A repeated
easures ANOVA revealed that all mice showed significant
patial acquisition (learning) across all four days of testing
t 4 months old ( F 3,84 = 20.9, p < 0.01), 6 months old
 F 3,81 = 6.62, p < 0.1) and 12 months old ( F 3,84 = 17,
 < 0.05). The mdx mice had the longest mean latency to find
he target hole (TH) for both short- and long-term memory
etween 4 and 12 months old. However, at 4 months old
here was no significant difference between control and mdx
ice with regard to short-term memory ( F 3,28 = 1.9, p = 0.1).
owever, at 12 months old the short-term memory of mdx
ice was significantly impaired compared to at 4 months
E. Bagdatlioglu, P. Porcari and E. Greally et al. / Neuromuscular Disorders 30 (2020) 368–388 379 
Fig. 7. a,b: Presentation of the VBM results produced by the SPM12 software with the SPMMouse plugin for grey matter of control versus mdx at various 
time points. The grey matter average shown is for the control mice and a coloured overlay showing the location of significant clusters. Red clusters indicate 
where control mouse brain is larger than mdx brain and blue indicates where mdx brain is larger than control brain. Colour intensity on the scale bar refers 
to the level of significance with a lighter colour indicating a higher level of significance ( p < 0.05, student’s t -test). a. Coronal images numbered 1–5 with 
corresponding sagittal image detailed image plane. (Grey matter average is from 8 control mice). b. Axial grey matter slices detailing VBM findings. 
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Fig. 8. a–e: Bilateral temporal muscle hypertrophy in mdx mice. a. Representative T 2 - weighted coronal images showing changes in head shape of the mdx 
mouse. There is hypertrophy of the temporal muscle in mdx mice causing a change in head shape compared to age matched control mice. b. Representative 
image demonstrating temporal muscle thickness measurements (yellow lines). c. There is bilateral temporal muscle hypertrophy in mdx mice at 12 months 
old compared to aged matched control mice. d. Evolution of the temporal muscle thickness (averaged values for left and right) with age in control and mdx 
mice e. Representative radiographs of the mouse skull aged 12 months old ( n = 4 mice per genotype). Yellow arrow represents widening of the squamosal 
bones. f. Bar graph displaying the widening of the squamosal bones in mdx mice at 12 months old compared to aged matched control mice ( p < 0.05). Data 
are presented as mean ± SEM, ∗p < 0.05, ∗∗p < 0.01 for control vs. mdx mice, n = 8 mice per genotype at each time point unless otherwise stated. 
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Fig. 9. a,b: Latency to find the target hole (TH) and the success scores during Barnes maze testing. a. Short-term and long-term memory retention on the 
Barnes maze test. Short-term memory and long-term memory were assessed on day five and day twelve, respectively. A single trial was given to each mouse 
on the Barnes maze and the primary and total errors and latency(s) were evaluated as in the acquisition phase. b. Success score (hole value multiplied by the 
number of head pokes) observed during short and long-term memory retention trials. The highest success scores are observed during the short-term memory 
retention trials across all genotypes. The mdx mice had the lowest success score, at all-time points, for both short and long-term memory compared to aged 
matched control mice. Data presented as mean ± SEM, ∗p < 0.05, ∗∗p < 0.01 for control vs. mdx , ^  p < 0.05, ^ ^ p < 0.01 for changes observed with ageing 
in mdx mice, $ < p .0.05 for changes observed with ageing in control mice. 
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mld where the mean latency was recorded as 50 ±14 s and
1 ±0.5 s, respectively. There was a significant interaction
etween genotype ∗age ( p = 0.018). The long-term memory of
dx mice was also significantly impaired between 4 and 12
onths old with a mean latency of 26 ±2.5 s and 59 ±13 s
ecorded, respectively. The control mice also showed a small
ecline in their short- and long-term memory abilities with
 10 s increase in the mean latency to target for both
hort and long-term memory between 4 and 12 months old
 Fig. 9 a). Additionally, the mdx mice made the largest number
f errors, both for short-term and long-term memory probe
rials, between 4 and 12 months old (see Supplementary
aterial 4 for more detail). 
The mdx mice displayed a high level of anxiety related
ehaviour, expressed as a complete freezing response, with
/8 mdx mice exhibiting this at 12 months old. Anxiety-
elated behaviour was not evident in the control mice at any
ime point investigated. The highest success score was recorded during the short-
erm memory probe trial for both genotypes ( Fig. 9 a,b).
he mdx mice had the lowest recorded success score for
oth short- and long-term memory at all-time points. The
uccess score in the mdx mice decreased between 4 and
2 months old for both short- and long-term memory. At
 months old, the mdx mice had a short-term memory
uccess score of 99 ±3 and 83 ±1 for long-term memory.
hereas, at 12 months old the mdx mice had a short-term
emory success score of 75 ±1.5 and 53 ±1 for long-term
emory. In contrast, the control mice had a success score
f 136 ±3 for short-term memory and 105 ±2 for long-term
emory. Given that the success score decreased in mdx mice
etween 4 and 12 months old, these findings suggest that mdx
ice have deterioration in cognitive function particularly in
emembering the position of the target hole during long-term
emory assessments. 
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Fig. 10. a,b: Bar graphs displaying novel object recognition (NOR) task results. a. Comparison of D2 ratios between 4 and 12 months old. The control mice 
had an increasing D2 ratio between 4 and 12 months old demonstrating an increased preference for the novel object. The mdx mice showed an increased 
preference for the familiar object at all-time points; however, the D2 ratio increased over time as the mice spent less time exploring the object in total. b. Bar 
graph displaying the amount of time that mice spent in the corners of the NOR arena between 4 and 12 months old. The control mice spent considerably less 
time in the corners during both the sample and choice phase compared to the mdx mice. At 4, 6 and 12 months old the mdx mice spent significantly longer 
in the corners during the sample and choice phases of NOR and this time increased with increasing age compared to control mice ( p < 0.05). Data presented 
as mean ± SEM, ∗p < 0.05, ∗∗p < 0.01 for control vs. mdx , ^ p < 0.05, ^^ p < 0.01 for changes observed with ageing in mdx mice, $ < p .0.05 for changes 
observed with ageing in control mice. 
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i  4.11. The mdx mice showed a higher preference for the 
familiar rather than the novel object during the NOR task 
During the sample phase of the NOR task, both genotypes
spent equal amounts of time with the two identical objects at
all-time points (4–12 months old), demonstrating that both
genotypes were equally interested with both objects (see
Supplementary Material 5 for more detail). Overall, the mdx
mice spent less time with the objects when compared to
the control mice at all-time points investigated, suggesting
that mdx mice have reduced exploratory behaviour possibly
as a consequence of increased anxiety related behaviour
(favouring to remain in the corners of the arena). During the
choice phase of the NOR task at 4 months old, the mdx
mice showed significant preference for the familiar object
(11 ±2 s) and spent significantly longer exploring the familiar
object compared to the novel object (6 ±1 s) ( p < 0.05)
( Fig. 10 a), suggesting that the mdx mice may have a
preference for the familiar and avoid the unfamiliar, which p  ight be related to fear, although this is speculative.
dditionally, during the choice phase of the NOR task at
 and 12 months old the mdx mice also spent a longer
mount of time investigating the familiar object compared
o the novel object but they also spent a longer amount of
ime ‘frozen’ in the corners of the NOR arena ( Fig. 10 b). At
ll-time points investigated the control mice showed
ignificant preference for the novel object, spending more
ime with the novel object with increasing age, represented
s a higher D2 ratio ( Fig. 10 a) suggesting that the control
ice have an intact recognition memory. 
. Discussion 
.1. Longitudinal non-invasive imaging 
This was the first study to investigate longitudinal changes
n the mdx mouse brain, scanning the same mice at each time
oint. A major finding of this study was that from 12 months
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c  nwards mdx mice has a significantly larger TBV compared to
ge matched controls. Previous MR imaging in mdx mice has
ot identified any differences in TBV; however, these studies
tilised mice aged 3 months old, and our study too found
o significant difference in TBV between control and mdx
ice at 3 months [41] . It is only with advanced age that
he mdx mouse TBV differed considerably to that of control
ice. Similarly, our studies are in accordance with Miranda
t al. who identified no change in TBV in the mdx mice at
 months old. Additionally, the study also found there to be
o significant differences in the volumes of the hippocampus
r cerebellum in mdx mice ( > 6 months old) which is in
greement with the findings of this study [43] . 
A striking finding of the study was the increase in TBV in
ontrol mice, which was not an expected result. We observed
ignificant, progressive, whole brain and regional volume
ncreases (brain ventricle system) in mature control mice,
here the increase began at 4 months old and brain growth
lowed down from 12 months onward. In contrast, the human
rain grows significantly between birth until our mid-teens,
hen brain growth begins to plateau, followed by a prolonged
eriod of stability in brain size before a very slow decline
atrophy) in later life [44 , 45] . In rodents, the closure of the
rowth plates is long delayed, which is opposite to that in
umans [46] . This effect, of increased TBV in rodents has
nly been documented once in a wild-type colony (C57BL/6 J
ackground) [47] , but is an important consideration when
tilising control mice to assess changes in brain morphology.
The most recent study utilising MR imaging in DMD
atients identified a reduction in TBV compared to that of
ealthy controls (although this was not found to be significant
 p = 0.056)). Patients in this study were split into two groups,
hose expressing Dp140 (Dp140 + ) but not Dp427 and patients
acking Dp140 (Dp140 −) and Dp427, with only the Dp140 −
roup showed a reduction in TBV. Additionally, most of the
MD patients in the study were currently taking steroids.
revious experiments have shown that steroids have an effect
n brain morphology; hence authors could not rule out steroid
se as a confounding factor for determining overall TBV.
tilising the mdx 4cv mouse (lacking Dp140 and Dp427) in
uture MR imaging experiments could help to determine how
he loss of Dp140 affects the mouse TBV. 
The lateral ventricles appeared to dilate significantly more
n mdx mice, relative to TBV increases, suggesting that
his is a pathological feature associated with full-length
ystrophin deficiency. Furthermore, enlarged ventricles in
oth DMD patients and in the mdx mice have been previously
eported at 10 months old. Within the choroid plexus (CP)
asolateral membrane, utrophin A colocalises with dystrophin
o control structural stability, transmembrane signalling, and
on/water homeostasis [48] . The loss of dystrophin could
ause reduced stability of the ventricles, allowing increased
SF to circulate causing ventricular expansion. Moreover,
everal studies have described correlations between the degree
f ventricular enlargement and the level of the cognitive
ysfunction or mental retardation [49] . Although obstruction
f the 4 V and/or the cerebral aqueduct has been known toause ventricular expansion [50] this was not evident on any
f the MR images acquired for the mdx mice. Additionally,
nlargement of the ventricular system may also be caused
y a failure of absorption or an overproduction of CSF,
tructural or functional impairments of cilia, and impaired
ell proliferation around ventricles [51] . The ependymal
ells of mdx mice were not investigated in this study, but
urther investigation is required to determine if dystrophin is
ecessary for the development of normal cerebral ventricles
nd neuroependymal integrity. 
Recent reports identified an enlarged hippocampal volume
n mdx mice aged 3 months old [52] ; however, we did not find
ny statistically significant differences between the relative
ippocampal volume of our control and mdx mice at any
ime point. Although at 18 months old the hippocampus was
maller in mdx mice this failed to reach statistical significance
 p > 0.05) ( Fig. 5 d). This difference could be explained by
he differing resolutions of the MR images obtained as our
rain scanning was performed in vivo and hence our scan
ime per mouse was much shorter than the post mortem
igh resolution scanning performed on the 3 month old mdx
ouse brains [41] . The higher resolution scanning allowed for
etter delineation of structures, in particular the hippocampus
hich borders are often hard to distinguish in lower resolution
cans due to CSF in the ventricles obscuring the hippocampal
oundaries. 
Many researchers argue that the cognitive abnormalities
ssociated with DMD could be classified as a cerebellar
isorder due to the absence of full-length dystrophin (Dp427-
) in the cerebellum [53] , and previous reports in the mdx
ice detail increased density of dystrophin protein in the
ateral versus the vermal mouse cerebellum [54] . We therefore
ncluded the entire cerebellum in our cerebellar volume
easurements, but found no difference in the cerebellar
olume or any gross structural abnormalities between control
nd mdx mice at any time point investigated, which is in
ccordance with studies in DMD patients [55 , 56] . These
ndings suggest that dystrophin loss does not cause any gross
bnormalities in the cerebellum but may have a further impact
t a cellular level, as previously reported in the mdx mouse
57] . Interestingly recently Dp427-p was found to be absent
rom the human brain [15] and it is evident that further studies
re necessary to ascertain fully the role and expression of
p427-p in both mouse and human cerebellum. 
The characteristic pathophysiological conditions caused 
y blood-brain barrier (BBB) disruption are brain oedema
esulting from an excessive increase of brain water content,
nflammatory damage caused by infiltrating immune cells,
nd haemorrhage caused by the breakdown of microvessel
tructures. The in vivo T 2 of brain tissue is related to
he local water environment and free-to-bound water ratio,
hich may change in response to cellular and axonal
oss or membrane breakdown. Changes in T 2 relaxometry
etected could signify a change in the brain water content
f mdx mice at 18 months old in the caudate putamen
nly. The water content ( T 2 relaxation rate) of the mdx
audate putamen at 6 months old was comparable to that
384 E. Bagdatlioglu, P. Porcari and E. Greally et al. / Neuromuscular Disorders 30 (2020) 368–388 
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o  of the control mouse. These results suggest that older mdx
mice may develop vasogenic cerebral oedema, as the BBB
becomes disrupted due to the breakdown of tight endothelial
junctions affecting the white matter through leakage from
capillaries [58] . Dystrophin and other members of the DGC
are expressed in brain microvessels [6] , and in astrocyte
perivascular endfeet [59] where dystrophin proteins play a
role in BBB functions. Previous studies have identified that
aquaporin-4 (AQP4) protein, the major water channel of the
CNS, are associated with the DGC in the brain [60] , at the
BBB interface the mdx mouse brain shows an age-related
reduction in AQP4 expression, with this reduction associated
with swollen astrocyte processes [61] . AQP4 deficiency was
also associated with BBB breakdown, causing vasogenic
oedema and swollen perivascular astrocytes, indicating a close
relationship between BBB integrity and control of the water
flux by astroglial cells [60] . Our findings suggest, for the
first time, the presence of vasogenic oedema in vivo in the
mdx mouse brain, and that this pathological feature progresses
with age, although further studies are necessary to confirm the
presence of vasogenic oedema. One limitation of this study
is that it is difficult to accurately delineate the rodent caudate
putamen on the MRI images acquired as this structure does
not have clear borders, therefore we chose to use a circular
ROI placed into centre of the caudate putamen as we felt that
this gave a good reflexion of the T 2 values from this brain
region. 
Moreover, our findings highlight the need for ongoing
dystrophin expression studies within the CNS. This study
identified elevated T 2 -relaxation rates in the caudate putamen
in the mdx mouse brain but there is little literature
regarding dystrophin expression within this particular region.
Additionally we also identified increased grey matter volume
of the mdx caudate putamen (following VBM), which is
in agreement with previous reports [41] . Unfortunately, the
caudate nucleus and putamen are not distinguishable in
rodents. The myelinated fibres that penetrate the striatum to
connect to the cerebral cortex and subcortical structures do
not form an internal capsule but are distributed throughout
the striatum in the rodent brain. Thus, the rodent striatum is
known as the ‘caudate putamen’. Functionally the striatum
co-ordinates multiple aspects of cognition in both rodents
[62] and humans [63] . Further studies are necessary to
elucidate the role of the caudate putamen in the mdx mice,
and further elucidate the expression pattern of dystrophin the
brain by visualisation with in-situ hybridisation techniques. 
VBM is routinely applied to the human brain to aid in
the diagnosis of neurological disorders but its application in
mouse brain is limited. VBM has been successfully applied
to the study of other neurological disorders in mice [31] ,
but this is the first study to apply VBM in the mdx mouse
brain. We identified numerous changes with VBM in the
mdx mouse brain where, the complexity of these changes
increased between 6 and 18 months old. Interestingly, the
mdx mice demonstrated enlargements in GM volume in the
lower layers of the cortex, amygdala, and caudate putamen,
in addition to reduced GM volume in the cerebellum, andippocampus, regions known to be dystrophin rich, where
he decrease in GM volume of these regions increased with
ge. These changes in the GM volume of the hippocampus
nd cerebellum could be linked to the cognitive dysfunction
bserved in mdx mice. The increased GM volume in the
mygdala may be linked to the increased anxiety related
ehaviour, which we observed in older mdx mice. We believe
hat VBM is much more sensitive method for the detection
f subtle changes in brain structure. The VBM findings
omplement the targeted and hypothesis led ROI analysis and
llowed a data-driven analysis. Given that the main changes
dentified by VBM were in the hippocampus and cerebellum,
tructures which contain/are close to either high CSF or white
atter in addition to grey matter, the boundaries on standard
 2 - w images for the hippocampus in particular could often
e hard to distinguish manually due to CSF in the ventricles
bscuring the view. We applied the minimum amount of
ost-processing to our VBM statistical data and present the
nalysis in the simplest form, with the result that the VBM
ata appears lightly noisy. We chose not to apply cluster-
ased thresholding approaches, which would improve the
isual appearance by removing the smallest findings based on
heir physical extent. Future application of VBM approaches
ould benefit from the use of higher resolution image data,
articularly with thinner slices than in our work, which would
mprove the intra-animal registration processes required for
BM. 
It has been previously reported that thicker temporal
uscles are associated with a more ovoid head shape in
MD patients compared to age matched controls [40] . We
lso observed a thickening of the temporal muscle in mdx
ice and a rounder head shape, which is the first time these
wo disease characteristics have been reported by MRI in
he mdx mouse. Taken together, this could suggest that the
eaker, hypertrophic cranial muscles, including the temporal
uscles, influence the development of the skull, resulting in a
ounder shape. In DMD patients, it is shown that mastication
s compromised and a decreased bite force is also reported.
iven that the temporal muscle thickening increased in mdx
ice between the ages of 4 and 18 months old, and their body
eights decreased between these time points it is plausible
hat elevated muscle pathology in the temporal muscles causes
ice to consume less food resulting in weight loss. 
.2. Longitudinal cognitive profiling 
Unlike DMD patients, adult mdx mice do not show
bvious progressive impairments in motor ability, presumably
s a consequence of differences between mice and men
egarding body size/architecture and a better regenerative
uscle capacity in mice [64] . The Barnes maze test and
he NOR task are not known to be strenuous activity tests,
nd thus were deemed acceptable behavioural assays to
mploy for the monitoring of a potential progressive cognitive
ysfunction in mdx mice up to 12 months old. Moreover, the
rogressive cognitive abnormalities detected in a small cohort
f DMD patients identified a progressive decline ultilising the
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mCST, which measures executive functions. The Barnes maze
ask is a goal-orientated task focusing on short/long-term
eference memory (and hippocampal-dependent) but could 
lso provide some information on executive functions in
odents including attention, inhibition, and working memory,
iven that the test involves the prefrontal cortex. 
In this present study we utilised the Barnes maze test and
umerous parameters (primary latency, total latency, primary
rrors, total errors, search pattern, and time spent in target
uadrants) to monitor if cognitive impairment is progressive
n mdx mice. It is only with a combination of these parameters
hat the progressive cognitive dysfunction becomes apparent.
he ageing control mice showed a reduction in their success
core (calculated during probe trials) between 4 and 12
onths old with the largest reduction detected in long-term
emory ability. The number of errors (primary and total
rrors) also increased with increasing age in control mice,
ut time spent in the target quadrant remained relatively
onstant between 4 and 12 months old during probe trials.
hese findings are consistent with previously published data
egarding the effect of ageing on control mice ( C57BL6J )
ehaviour [65] , which suggested that impaired spatial and
earning memory on the Barnes maze test is evident with
ncreasing age, and further indicates that relatively narrow age
ifferences can produce significant behavioural differences 
uring adulthood in mice. In the mdx mice these parameters
success score, number of errors, time spent in the target
uadrant) were affected to a greater extent. In particular, the
ime spent in the target quadrant, during short-term memory
robe trial, was significantly reduced between 4 and 12
onths old, as was the short-term memory (as shown by a
ecreasing success score and an increased number of errors).
he long-term memory of mdx mice appears to show the
ighest deficit between 4 and 12 months old compared to the
ong-term memory defect of control mice. 
Long-term memory impairment in DMD has recently been
eported [28 , 66] . Dp427 appears to play a role in acquisition
f associated learning as well as in general processes involved
n memory consolidation following the assessment of mdx
ice in this current study. Furthermore, it has been reported
hat long-term spatial memory is a function of the CA1
ippocampal sub-region and that this area has less of a role in
hort term memories [67] . Given that the Barnes maze test we
erformed highlighted in particular a reduction in long-term
emory ability in the mdx mice between 4 and 12 months
ld, it is likely down to abnormalities in the CA1 field of the
ippocampus. 
The long-term memory impairments in mdx mice suggest
 direct link with the loss of full-length dystrophin, therefore
ffecting all DMD patients. However, previous studies in the
dx identified that loss of full-length dystrophin has no effect
n perception and gating of sensory input and does not impair
patial working memory performance ( mdx mice aged 3–4
onths old) [28] . Our study has highlighted that whilst at
 months old spatial learning and memory in the mdx mice
s comparable to that of control mice as the mdx mice age6 months onwards), spatial learning and memory becomes
ignificantly impaired. 
Novelty and behaviour has gained much attention and
nterest from researchers. Novelty can be defined as an
lteration from the expected likelihood of an event on the
asis of both previous information and internal estimates of
onditioned probabilities [68] . A novel stimulus can affect an
nimals’ behaviour and the NOR task relies on the rodents’
nnate exploratory behaviour in the absence of externally
pplied rules or reinforcement [35 , 36] . The preference for
he novel object means that presentation of the familiar
bject exists in the animals’ memory [68] . The recognition
f novelty requires more cognitive skills from the subject,
elative to tasks measuring exploration of novel environments
It is widely acknowledged that NOR paradigms are
nfluenced by both hippocampal and cortical lesions [42] .
he hippocampus is important for object recognition memory;
amage to hippocampal structures causes moderate and
eliable anterograde memory impairment. A rodent that
emembers the familiar object will spend more time exploring
he novel object [35] . DMD patients have demonstrated
mpairments in visual recognition memory (during Peabody 
icture vocabulary tests) [69] . The mdx mice displayed a
reference for the familiar object, and were opposed to the
ovel object, at all-time points, which may rather suggest that
dx mice avoid the novel object because of anxiety and prefer
o stay with the familiar one. As mdx mice didn’t spend
he same amount of time with both objects, which would
uggest impaired visual memory, the NOR task may measure
ore than visual memory. The time spent with the familiar
bject did not increase over time but the amount of time that
he mice spent with the objects in total decreased between
 and 12 months old. These findings highly suggest that
he loss of Dp427 from the mdx hippocampus has a direct
ffect on recognition memory formation, given the higher
reference for the familiar object the mdx mice exhibited.
he amount of time the mdx mice spent in the corners
frozen) of the NOR arena increased between 4 and 12 months
ld and is indicative of increased anxiety-related behaviour.
his freezing behaviour has previously been reported in mdx
ice, but this is the first time this anxiety-like behaviour
as been observed to increase with increasing age in mdx
ice. 
Remarkably mdx mice also displayed repetitive behaviour,
onsistent with autistic-like traits in mice [70] . At 12
onths old 3/8 mdx mice displayed stereotypical behaviours
ssociated with autistic traits in mice including spontaneous
otor stereotypes: circling the inside walls of the arena
nd jumping repeatedly. These characteristics were most
rominent in mdx mice at 12 months old. Additionally,
dx mice displayed similar traits to those seen in mice of
eurodegenerative disease. For example the earliest cognitive
eficits in mouse models of Alzheimer’s disease have been
hown at 6 months of age by multiple groups [71 , 72] ,
nd Alzheimer’s mice showed reduced spatial learning and
emory during the Barnes maze task [73] . 
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 The control mice showed an increased preference for the
novel object with increasing age and these findings are in
congruence with previous literature examining the effects of
ageing on rodents’ performance during the NOR tasks [74] . 
Furthermore, previous reports detail a potent freezing
response in male mdx mice, expressed as lasting tonic
immobility, reminiscent of the natural defensive death-
feigning posture that animals exhibit when confronted by a
predator or other threat, which is theorised to involve a brain
circuit that includes the amygdala [75] . Authors suggest that
if mdx mice were group housed rather than singly housed,
and exposed to a familiar environment, this response could
be reduced. In this present study male mdx mice were group
houses (average 4 males per cage) and exposed to the same
maze for 5 consecutive days, and yet a proportion of mdx
mice still exhibit complete lasting tonic immobility (freezing
response) at 12 months old during the Barnes maze test. This
phenotype could be used to potentially assess the dynamics of
therapeutic agents targeting brain dysfunctions in this model
of DMD, as similarly suggested by Vaillend and Chaussenot
[75] . 
Although mdx mice were subjected to repeated behavioural
testing, the testing sessions were very short ( < 15 min total
per day, with an inter trial interval of 15 min) and were
only performed for 5 consecutive days. Neither the NOR task
or the Barnes maze test are strenuous activities, therefore,
we do not believe that fatigue related to muscle structure
and/or functional integrity had any impact on how the mdx
mice performed the task. Additionally, other studies
demonstrate that muscle impairments are not noticeable in
the mdx mouse model until much older in age, hence we did
not include any 18 month old mdx mice in our behavioural
assessments [37–39] . 
6. Summary 
Overall, our study suggests that there is a progressive
decline in cognitive function with age in mdx mice. Utilising
a combination of techniques this is the first study, to the
best of our knowledge, to demonstrate clear progressive
CNS pathology in the mdx mice. We have identified non-
invasive measures to detect several longitudinal changes in
cognitive function and brain morphology in the mdx mouse,
including: enlarged cerebral ventricles; larger total brain
volume; and increased primary latency on the Barnes maze
test. These findings have important implications for future
studies examining the neurophysiological consequence of
neuronal dystrophin deficiency and how its loss impacts brain
morphology and cognition overtime. As the life expectancy of
DMD patients has increased considerably over the past few
decades [76] , a better understanding of the cognitive profile
in older DMD patients is vital as a progressive cognitive
impairment will have direct implications on DMD patients’
overall quality of life. 
This study suggests that dystrophin-deficiency results in
late onset neurodegeneration that isn’t observed in DMD
patients because of their reduced life expectancy. Beckeruscular dystrophy (BMD) patients on the other hand still
ave residual dystrophin expression and therefore might not
how the same late-onset progression of CNS symptoms as
bserved during this mdx mouse study. 
upplementary materials 
Supplementary material associated with this article can be
ound, in the online version, at doi: 10.1016/j.nmd.2020.02.
18 . 
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